CARD9 p.Cys402Arg
c.1204T>C · rs773952828 · VCV2390310
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0463 | likely benign |
|---|---|---|
| REVEL | 0.042 | moderately benign-leaning |
| SaProt | LLR -3.21 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · A>C here scores Δ0.75 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP -0.86 | GERP -3.4 |
| Regional constraint | o/e 1.03 | unconstrained · MANE · 7,773 bp · p 0.34 · regional, not allelic |
| Overall | ||
| CADD | 0.26 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.00321% | 31,144 |
| European (non-Finnish)grpmax | 0.00271% | 36,844 |
| Admixed American | 0.00167% | 59,800 |
| African / African-American | 0.00134% | 74,882 |
| South Asian | 0.00111% | 90,422 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CARD9
- Protein
- p.Cys402Arg
- Coding
- c.1204T>C
- MANE Select
- NM_052813
- dbSNP
- rs773952828
- Type
- single nucleotide variant
- Location
- chr9:136367702 (GRCh38)
- Gene constraint
- LOEUF 1.143 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 81.24 · 8 PDB
- Residue 402
- a UniProt-annotated variant site (in imd103; reduced cytokine production in response to c.albicans infection; impaired nf-kappa-b transcriptional activity); a UniProt-annotated variant site (in imd103; decreased production of cytokines in cd4(+) th17 cells); a UniProt-annotated variant site (in imd103; reduced production igg antibodies in response to c.albicans infection); a UniProt-annotated variant site (in imd103; reduced cytokine production in response to c.albicans infection)
Similar variants
- CARD9 p.Ala109Val Uncertain significance ★★ ⚠ same condition
- CARD9 p.Ala190Val Uncertain significance ★★ ⚠ same condition
- CARD9 p.Ala198Thr Uncertain significance ★★ ⚠ same condition
- CARD9 p.Ala369Thr Uncertain significance ★★ ⚠ same condition
- CARD9 p.Ala392Val Uncertain significance ★★ ⚠ same condition
- CARD9 p.Arg173Cys Uncertain significance ★★ ⚠ same condition
- CARD9 p.Arg241Trp Uncertain significance ★★ ⚠ same condition
- CARD9 p.Arg315Leu Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/card9-p-cys402arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown